shuanghuanglian
oral
liquid
shl
wellknown
chines
patent
drug
contain
three
herbal
medicin
radix
scutellaria
flo
lonicera
japonica
fructu
forsythia
usual
use
treat
acut
upper
respiratori
tract
infect
caus
viru
bacteria
although
licens
botan
drug
veregen
approv
fda
indic
import
quantit
analysi
qualiti
control
herbal
medicin
quantit
evalu
chines
patent
drug
like
shl
remain
challeng
due
complex
chemic
profil
studi
small
molecular
compon
shl
four
flavonoid
six
quinic
acid
deriv
three
saponin
two
phenylethanoid
glycosid
simultan
determin
use
ultrahigh
perform
liquid
chromatographi
coupl
quadrupoletimeofflight
mass
spectrometri
uhplcqtofm
content
three
major
saccharid
name
fructos
glucos
sucros
quantifi
use
high
perform
liquid
chromatographyevapor
light
scatter
detector
amino
column
hplcelsd
macromolecul
quantifi
precipit
ethanol
dri
precipit
weigh
establish
method
valid
term
linear
sensit
precis
accuraci
stabil
success
appli
analyz
batch
commerci
product
shl
produc
four
differ
manufactur
result
indic
ww
shl
could
quantit
determin
nonsaccharid
small
molecul
monosaccharid
macromolecul
sucros
studi
may
provid
use
way
comprehens
evalu
qualiti
shl
shuanghuanglian
oral
liquid
shl
popular
chines
patent
drug
use
treat
acut
upper
respiratori
tract
infect
caus
viru
bacteria
compris
three
herb
radix
scutellaria
flo
lonicera
japonica
fructu
forsythia
ratio
www
sinc
outbreak
sever
acut
respiratori
syndrom
commerci
demand
shl
steadili
increas
drug
produc
sever
manufactur
annual
output
shl
one
manufactur
reach
million
bottl
annual
revenu
usd
million
annual
growth
rate
shl
becom
lead
choic
prevent
treat
windheat
type
common
cold
china
consid
great
demand
shl
criteria
level
qualiti
control
shl
becom
import
record
chines
pharmacopeia
baicalin
radix
scutellaria
chlorogen
acid
flo
lonicera
japonica
forsythin
fructu
forsythia
select
chemic
marker
qualiti
evalu
wide
report
qualit
quantit
analys
shl
purpos
qualiti
control
document
use
high
perform
liquid
chromatographi
hplc
method
assay
major
chemic
marker
baicalin
chlorogen
acid
forysthin
chines
patent
drug
may
consist
http
elsevi
bv
right
reserv
hundr
even
thousand
compon
respons
therapeut
effect
synergist
andor
antagonist
interact
shl
complex
chemic
profil
wide
rang
compon
includ
phenylethanoid
glycosid
lignan
quinic
acid
saponin
flavonoid
compon
might
contribut
therapeut
efficaci
differ
way
thu
identif
quantit
determin
three
activ
marker
suffici
qualiti
control
shl
although
studi
publish
qualit
analysi
constitu
shl
high
perform
liquid
chromatographymass
spectrometri
hplcm
anoth
studi
even
detect
compound
includ
prototyp
compon
metabolit
human
serum
shuanghuanglian
inject
administr
signific
improv
quantit
analysi
made
intern
gold
standard
pharmaceut
approv
fda
fda
approv
drug
consid
safe
enter
world
commerc
fda
approv
depend
analysi
drug
quantif
compon
far
two
botan
drug
fulyzaq
veregen
approv
fda
drug
complex
chemic
profil
yet
chemic
compon
quantit
determin
qualiti
evalu
chines
patent
drug
includ
shl
win
fda
approv
higher
level
quantit
analysi
must
achiev
product
water
decoct
shl
contain
small
molecul
macromolecul
particularli
larg
amount
carbohydr
includ
monosaccharid
oligosaccharid
polysaccharid
publish
analyt
method
miss
carbohydr
could
fulli
meet
requir
fda
thu
develop
power
qualit
quantit
method
urgent
bring
shl
intern
market
studi
comprehens
combin
method
develop
determin
nonsaccharid
small
molecul
use
ultrahigh
perform
liquid
chromatographi
coupl
quadrupoletimeofflight
mass
spectrometri
uhplcqtofm
determin
saccharid
use
high
perform
liquid
chromatographyevapor
light
scatter
detector
amino
column
hplcelsd
determin
macromolecul
precipit
dri
weight
method
valid
success
appli
analyz
batch
shl
four
differ
manufactur
commerci
product
shl
produc
four
differ
manufactur
purchas
drug
store
mainland
china
name
b
c
three
batch
sampl
differ
produc
time
collect
manufactur
batch
concentr
oral
liquid
refer
substanc
neochlorogen
acid
forsythosid
e
chlorogen
acid
cryptochlorogen
acid
forsythosid
isochlorogen
acid
b
isochlorogen
acid
isochlorogen
acid
c
baicalin
oroxylin
wogonosid
macranthoidin
b
macranthoidin
dipsacosid
b
baicalein
provid
chengdu
prefer
biotechnolog
co
ltd
chengdu
china
refer
substanc
fructos
glucos
sucros
suppli
sigma
st
loui
usa
hplc
grade
acetonitril
acn
methanol
ethanol
formic
acid
studi
obtain
merck
darmstadt
germani
water
use
prepurifi
millipor
milliq
water
purif
system
bedford
usa
refer
substanc
neochlorogen
acid
forsythosid
e
chlorogen
acid
cryptochlorogen
acid
forsythosid
isochlorogen
acid
b
isochlorogen
acid
isochlorogen
acid
c
baicalin
baicalein
accur
weigh
dissolv
methanol
oroxylin
wogonosid
macranthoidin
b
macranthoidin
dipsacosid
b
dissolv
methanol
solut
mix
prepar
stock
solut
standard
anoth
mix
standard
stock
solut
prepar
dissolv
accur
weigh
refer
substanc
fructos
glucos
sucros
acnwat
vv
work
standard
solut
obtain
calibr
curv
later
appropri
dilut
two
mix
standard
solut
shl
sampl
ml
taken
dilut
time
methanol
make
sampl
solut
uhplcm
analysi
small
molecul
solut
filter
membran
analysi
sampl
solut
work
standard
solut
standard
curv
need
inject
parallel
analysi
saccharid
ml
shl
product
freezedri
first
labconco
seri
dri
powder
accur
weigh
dissolv
water
make
ml
solut
ethanol
precipit
ml
ethanol
ad
ethanol
precipit
solut
left
overnight
solut
centrifug
rpm
min
supernat
precipit
collect
supernat
condens
remov
ethanol
dissolv
ml
acnwat
vv
make
sampl
solut
hplcelsd
analysi
fructos
glucos
sucros
precipit
dri
weigh
give
macromolecul
content
uhplc
data
produc
use
agil
uhplc
system
agil
technolog
santa
clara
usa
equip
binari
pump
thermostat
column
compart
autosampl
degass
ms
data
perform
agil
qtof
mass
spectromet
agil
technolog
santa
clara
usa
equip
quadrupoletimeofflight
qtof
mass
spectromet
jetstream
electrospray
ion
esi
sourc
data
acquisit
control
softwar
agil
technolog
optim
oper
paramet
neg
ion
mode
follow
nebul
ga
n
flow
rate
lmin
nebul
ga
temperatur
c
jet
stream
ga
flow
lmin
sheath
ga
temperatur
c
nebul
psi
capillari
v
skimmer
v
oct
rfv
v
fragmentor
voltag
v
msm
techniqu
could
provid
parallel
altern
scan
acquisit
low
collis
energi
obtain
precursor
ion
inform
ramp
high
collis
energi
obtain
fullscan
accur
mass
fragment
precursor
ion
neutral
loss
inform
collis
energi
auto
msm
analysi
v
v
respect
mass
spectra
record
across
rang
mz
accur
mass
measur
mass
peak
saccharid
determin
agil
liquid
chromatograph
system
agil
technolog
palo
alto
usa
alltech
evapor
lightscatt
detector
grace
deerfield
usa
use
chromatograph
separ
perform
asahipak
nh
mm
mm
shodex
tokyo
japan
column
maintain
c
mobil
phase
consist
water
acn
b
min
b
min
b
min
b
flow
rate
mlmin
drift
tube
temperatur
elsd
set
c
nitrogen
flow
rate
elsd
set
lmin
gain
number
equal
develop
uhplcqtofm
method
evalu
linear
sensit
repeat
stabil
accuraci
stock
solut
fifteen
refer
compound
dilut
appropri
concentr
construct
calibr
curv
least
eight
concentr
solut
analyz
duplic
linear
calibr
curv
gener
plot
peak
area
versu
correspond
concentr
limit
detect
lod
quantit
loq
present
chromatograph
condit
determin
signaltonois
ratio
sn
around
respect
repeat
stabil
method
also
evalu
analyt
analysi
repeat
six
time
day
addit
three
consecut
day
determin
intraday
precis
interday
precis
respect
sampl
store
c
analyz
h
stabil
test
rsd
standard
deviationmean
recoveri
test
use
evalu
accuraci
develop
uhplcqtofm
method
accuraci
determin
ad
standard
solut
three
differ
concentr
level
shl
sampl
content
analyt
known
sampl
dilut
methanol
analyz
parallel
accord
propos
method
triplic
experi
perform
level
spike
recoveri
calcul
follow
equat
spike
recoveri
total
amount
detect
amount
origin
amount
spike
method
hplcelsd
quantit
analysi
evalu
linear
sensit
repeat
stabil
accuraci
valid
measur
uhplcqtofm
method
note
calibr
curv
prepar
plot
logarithm
peak
area
logarithm
correspond
concentr
neg
ion
mode
select
ms
analysi
studi
provid
extens
clear
structur
inform
posit
mode
detect
shl
ingredi
typic
total
ion
current
tic
chromatogram
shl
sampl
mix
standard
given
fig
fifteen
compound
total
unambigu
identifi
compar
retent
time
accur
mz
data
refer
substanc
tabl
among
compound
four
flavonoid
baicalin
oroxylin
wogonosid
baicalein
radix
scutellaria
six
quinic
acid
deriv
neochlorogen
acid
chlorogen
acid
cryptochlorogen
acid
isochlorogen
acid
b
isochlorogen
acid
isochlorogen
acid
c
three
saponin
macranthoidin
b
macranthoidin
dipsacosid
b
flo
lonicera
two
phenylethanoid
glycosid
forsythosid
e
forsythosid
fructu
forsythia
chemic
structur
provid
fig
high
precis
msm
fragment
inform
obtain
list
tabl
saccharid
analysi
three
peak
chromatogram
identifi
fructos
glucos
sucros
respect
compar
retent
time
refer
standard
fig
b
shown
tabl
uhplcqtofm
method
calibr
curv
show
good
linear
coeffici
r
less
loq
lod
analyt
less
ngml
respect
rel
standard
deviat
rsd
intraday
precis
interday
precis
stabil
less
respect
indic
good
precis
method
sampl
stabil
establish
method
also
accept
accuraci
spike
recoveri
analyt
hplcelsd
method
good
linear
demonstr
linear
rang
lod
fructos
glucos
sucros
mgml
respect
loq
fructos
glucos
sucros
mgml
respect
rel
standard
deviat
rsd
intraday
precis
interday
precis
stabil
less
respect
whilst
accuraci
within
actual
valu
level
result
demonstr
develop
uhplcqtofm
hplcelsd
method
suffici
reliabl
accur
quantif
eighteen
investig
compound
shl
newli
establish
uhplcqtofm
hplcelsd
analyt
approach
subsequ
appli
determin
amount
fifteen
nonsaccharid
small
molecul
three
saccharid
batch
commerci
shl
produc
four
manufactur
peak
area
extract
ion
chromatogram
fifteen
nonsaccharid
small
molecul
calcul
put
calibr
curv
gener
plot
peak
area
correspond
concentr
peak
area
shown
elsd
chromatogram
put
calibr
curv
three
saccharid
prepar
plot
logarithm
peak
area
logarithm
correspond
concentr
multipl
dilut
time
concentr
compound
commerci
shuanghuanglian
oral
liquid
known
result
summar
tabl
percentag
chemic
found
studi
summar
fig
shown
tabl
fig
total
content
analyt
batch
reach
batch
total
content
analyt
exist
rel
low
level
close
result
indic
ww
shl
could
quantit
determin
includ
nonsaccharid
small
molecul
monosaccharid
macromolecul
sucros
still
chemic
shl
remain
unidentifi
reason
may
contain
amino
acid
inorgan
salt
auxiliari
materi
essenc
view
content
compound
nonsaccharid
small
molecul
carbohydr
vari
significantli
among
batch
studi
show
qualiti
commerci
shl
inconsist
variat
may
result
differ
aspect
sourc
raw
materi
procedur
process
manufactur
standard
qualiti
control
differ
manufactur
exampl
three
saponin
macranthoidin
b
macranthoidin
dipsacosid
b
show
greatest
variat
sampl
amount
macranthoidin
b
time
batch
saponin
could
even
detect
report
flo
lonicera
japonica
sampl
differ
origin
contain
chlorogen
acid
galuteolin
without
macranthoidin
b
dipsacosid
b
compound
number
fig
fig
b
unit
rang
loq
loq
fructos
glucos
sucros
mgml
content
chemic
determin
batch
shl
sampl
gml
lonicera
flo
total
content
macranthoidin
b
dipasacosid
b
high
galuteolin
found
studi
infer
lonicera
japonica
flo
substitut
lonicera
flo
manufactur
macranthoidin
b
dipasacosid
b
batch
purchas
drug
store
significantli
detect
experi
sampl
manufactur
c
detect
macranthoidin
b
dipasacosid
b
content
dipasacosid
b
rel
small
therefor
deduc
preliminarili
lonicera
japonica
flo
use
produc
shuanghuanglian
oral
liquid
commonli
seen
lonicera
flo
use
substitu
lonicera
japonica
flo
product
chines
patent
drug
except
inject
due
saponin
risk
function
accord
chines
pharmacopeia
furthermor
sucros
flavor
agent
ad
differ
amount
batch
illustr
tabl
amount
sucros
mgml
product
manufactur
b
mgml
batch
import
unlik
artifici
sweeten
cyclam
affect
tast
sucros
also
show
synergist
antibacteri
effect
antiinflammatori
ingredi
howev
shl
may
accept
specif
group
elderli
patient
diabet
due
high
concentr
sugar
sucros
shl
product
thu
content
sugar
ad
chines
patent
drug
need
concern
addit
concentr
oral
liquid
compar
two
normal
prepar
produc
manufactur
case
content
chemic
ingredi
higher
shown
tabl
howev
certain
compound
isochlorogen
acid
c
baicalin
show
larger
amount
whilst
forsythosid
show
obviou
differ
among
three
batch
content
forsythosid
e
even
lower
two
batch
base
observ
consid
reform
concentr
oral
liquid
produc
manufactur
express
enhanc
compar
normal
oral
liquid
compar
report
method
new
method
abl
quantifi
total
chemic
profil
commerci
shl
level
ensur
effect
qualiti
commerci
product
bring
qualiti
control
chines
patent
drug
requir
fda
method
may
appli
herbal
formula
especi
seek
fda
approv
studi
effici
combin
uhplcqtofm
hplcelsd
analyt
method
establish
valid
determin
major
compon
shl
success
appli
qualiti
evalu
commerci
shl
result
show
chemic
shl
quantifi
control
also
effect
reveal
signific
variat
qualiti
commerci
oral
liquid
research
also
provid
wellround
approach
qualiti
investig
chines
patent
drug
